Ticker Details
Organon & Co..
IPO Date:	May 14, 2021
Sector:	Healthcare
Industry:	Drug Manufacturers - General
Market Cap:	$3.53B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.33 | 1.72%
Avg Daily Range (30 D):	$0.17 | 1.79%
Avg Daily Range (90 D):	$0.18 | 2.28%

Institutional Daily Volume
Avg Daily Volume:	2.81M
Avg Daily Volume (30 D):	13.01M
Avg Daily Volume (90 D):	7.06M

Trade Size
Avg Trade Size (Sh.):	113
Avg Trade Size (Sh.) (30 D):	272
Avg Trade Size (Sh.) (90 D):	197

Institutional Trades
Total Institutional Trades:	4,606
Avg Institutional Trade:	$3.4M
Avg Institutional Trade (30 D):	$2.42M
Avg Institutional Trade (90 D):	$2.54M
Avg Institutional Trade Volume:	.19M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$7.75M
Avg Closing Trade (30 D):	$8.32M
Avg Closing Trade (90 D):	$6.16M
Avg Closing Volume:	435.44K

News

May 22, 2026 @ 6:20 AM Hanmi Pharmaceutical se asocia con Organon para ex... Source: Na

May 22, 2026 @ 6:20 AM Hanmi Pharmaceutical Faz Parceria com a Organon pa... Source: Na

May 14, 2026 @ 5:51 PM BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Inve... Source: Brodsky & Smith

May 7, 2026 @ 1:14 AM Halper Sadeh LLC is Investigating Whether HLX, OGN... Source: Halper Sadeh Llc

May 5, 2026 @ 6:53 PM Halper Sadeh LLC is Investigating Whether MKC, LEG... Source: Halper Sadeh Llc

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$.94	$.56	$-.79
Diluted EPS	$.94	$.55	$-.78
Revenue	$6.16B	$1.46B	$1.51B
Gross Profit	$3.26B	$783M	$741M
Net Income / Loss	$246M	$146M	$-205M
Operating Income / Loss	$537M	$213M	$-148M
Cost of Revenue	$2.91B	$677M	$766M
Net Cash Flow	$569M	$542M	$-98M
PE Ratio